DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Gruenberger T. et al.
Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial.
Ann Oncol 2015;
26: 702-708
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.